| 名稱 | AI-Edigene® EGFR p.L861Q Reference Standard P |
| 型號 | CBP10401 |
| 報(bào)價 |  |
| 特點(diǎn) | AI-Edigene® EGFR p.L861Q Reference Standard Plus |
產(chǎn)品搜索
相關(guān)文章
- IL-11藥物細(xì)胞模型介紹
- 細(xì)胞株培養(yǎng)傳代時的指數(shù)增生期解讀
- 【新品發(fā)布】MRD標(biāo)準(zhǔn)品_40+位點(diǎn)panel標(biāo)準(zhǔn)品
- 【連載-企業(yè)參考品】乳腺癌的PCR和NGS參考品的選擇
- 細(xì)胞株購買以及真假鑒別雜談
- 【靶點(diǎn)模型+診斷質(zhì)控】FLT3-ITD的藥物開發(fā)和診斷
- Cell Rep：發(fā)現(xiàn)治療乳腺癌轉(zhuǎn)移的重要新靶標(biāo)！
- PD-1/L1 &4-1BB雙靶點(diǎn)細(xì)胞篩選模型
- 【產(chǎn)品推介】LAG-3靶點(diǎn)細(xì)胞篩選模型
- 國內(nèi)研究者Cell Research：韓春雨NgAgo有效
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Mutation > CBP10401AI-Edigene® EGFR p.L861Q Reference Standard P
- 詳細(xì)內(nèi)容
" _ue_custom_node_="true">
CBP10401 | |
| Format | Genomic DNA |
| Description | The L861Q mutation results in an amino acid substitution at position 861 in EGFR, from a leucine (L) to a glutamine (Q). This mutation occurs within exon 21, which encodes part of the kinase domain, and occurs with a frequency of approximately 2% in EGFR-mutated lung tumors (Mitsudomi and Yatabe 2010). This mutation is associated with increased sensitivity to the EGFR TKIs, erlotinib (Tarceva) and gefitinib (Iressa; Lynch et al. 2004). |
| Technical Data | |
| DNA Change | c.2582T>A |
| AA Change | p.L861Q |
| Mutation type | Substitution - Missense |
| Zygosity | Homozygous |
| Allelic Frequency | 100% |
| Transcript | ENST00000275493 |
| Cosmic ID | COSM6213 |
| Chr position(GRCh37) | chr7:55259524 |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
